{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T18:08:58Z","timestamp":1758046138203,"version":"3.44.0"},"reference-count":17,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2007,12,1]],"date-time":"2007-12-01T00:00:00Z","timestamp":1196467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,12,1]],"date-time":"2007-12-01T00:00:00Z","timestamp":1196467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales d'Endocrinologie"],"published-print":{"date-parts":[[2007,12]]},"DOI":"10.1016\/j.ando.2007.08.003","type":"journal-article","created":{"date-parts":[[2008,1,26]],"date-time":"2008-01-26T20:31:41Z","timestamp":1201379501000},"page":"464-466","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Insuffisance aortique sous\u00a0faibles doses de\u00a0cabergoline pour\u00a0hyperprolactin\u00e9mie non tumorale"],"prefix":"10.1016","volume":"68","author":[{"given":"I.","family":"Belleville","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Chague","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.-M.","family":"Petit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Boujon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ando.2007.08.003_bib1","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1056\/NEJMoa062222","article-title":"Dopamine agonists and the risk of cardiac-valve regurgitation N","volume":"356","author":"Schade","year":"2007","journal-title":"Engl. J. Med."},{"key":"10.1016\/j.ando.2007.08.003_bib2","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1056\/NEJMoa054830","article-title":"Valvular heart disease and the use of Dopamine agonists for Parkinson\u2019s disease N","volume":"356","author":"Zanettini","year":"2007","journal-title":"Engl.J.Med."},{"key":"10.1016\/j.ando.2007.08.003_bib3","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S0755-4982(05)84028-X","article-title":"Quand et comment traiter une hyperprolactin\u00e9mie?","volume":"34","author":"Bachelot","year":"2005","journal-title":"Presse Med."},{"key":"10.1016\/j.ando.2007.08.003_bib4","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ando.2006.11.001","article-title":"Diagnostic et prise en charge des hyperprolactin\u00e9mies. Consensus d\u2019experts de la Soci\u00e9t\u00e9 fran\u00e7aise d\u2019endocrinologie","volume":"68","author":"Brue","year":"2007","journal-title":"Ann. Endocrinol."},{"key":"10.1016\/j.ando.2007.08.003_bib5","first-page":"225","article-title":"Effectiveness of long-term cabergoline treatment for giant prolactioma: study of 12 men Eur","volume":"156","author":"Shimon","year":"2007","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.ando.2007.08.003_bib6","first-page":"870","article-title":"Risk for valvular heart disease among users of Fenfluramine and Dexfenfluramine who underwent echocardiography before use of medication Ann","volume":"129","author":"Wee","year":"1998","journal-title":"Intern. Med."},{"key":"10.1016\/j.ando.2007.08.003_bib7","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1161\/01.CIR.100.21.2161","article-title":"Prevalence and determinants of valvulopathy in patients with Dexfenfluramine","volume":"100","author":"Shively","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.ando.2007.08.003_bib8","first-page":"2","article-title":"Appetite suppressants and valvular heart disease \u2014\u00a0a systematic review","volume":"16","author":"Loke","year":"2002","journal-title":"BMC Clin. Pharmacol."},{"key":"10.1016\/j.ando.2007.08.003_bib9","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s00702-005-0289-1","article-title":"Retrospective evaluation of cardio-pulmonary fibrotic side effects in symptomatic patients from a group of 234 Parkinson\u2019 disease patients treated with cabergoline","volume":"112","author":"Dhawwan","year":"2005","journal-title":"J. Neural. Transm."},{"key":"10.1016\/j.ando.2007.08.003_bib10","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1001\/archneur.64.3.377","article-title":"Cardiac valve regurgitation with pergolide compared with nonergot agonists in Parkinson\u2019s disease","volume":"64","author":"Dewey","year":"2007","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.ando.2007.08.003_bib11","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/S0140-6736(04)15945-X","article-title":"Treatment of Parkinson\u2019s disease with pergolide and relation to restrictive valvular heart disease","volume":"363","author":"Van Camp","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.ando.2007.08.003_bib12","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.clineuro.2007.01.011","article-title":"Assesment of valvulopathy in Parkinson\u2019s disease patients on pergolide and\/or cabergoline","volume":"109","author":"Kenagil","year":"2007","journal-title":"Clin. Neurol. Neurosurg"},{"key":"10.1016\/j.ando.2007.08.003_bib13","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1212\/01.wnl.0000238508.68593.1d","article-title":"Dopamine agonists and cardiac valvulopathy in Parkinson\u2019s disease","volume":"67","author":"Yamamoto","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.ando.2007.08.003_bib14","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1016\/j.ijcard.2006.07.020","article-title":"Mitral heart disease due to cabergoline","volume":"114","author":"Martin","year":"2007","journal-title":"Intern J. of Cardiology"},{"key":"10.1016\/j.ando.2007.08.003_bib15","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.clinthera.2006.08.004","article-title":"A review of the receptor-binding and pharmacokinetic properties of dopamine agonists","volume":"28","author":"Kvernmo","year":"2006","journal-title":"Clin. Thera."},{"key":"10.1016\/j.ando.2007.08.003_bib16","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1161\/01.CIR.102.23.2836","article-title":"Evidence for possible involvement of 5-HT2B receptors in the cardiac valvulopathy associated with fenfluramine and others serotoninergic medications","volume":"102","author":"Rothman","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.ando.2007.08.003_bib17","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1056\/NEJMp068265","article-title":"Drugs and valvular heart disease","volume":"356\u20133","author":"Roth","year":"2007","journal-title":"N. Engl. J. Med."}],"container-title":["Annales d'Endocrinologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003426607001953?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003426607001953?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T22:41:45Z","timestamp":1757716905000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003426607001953"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12]]},"references-count":17,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["S0003426607001953"],"URL":"https:\/\/doi.org\/10.1016\/j.ando.2007.08.003","relation":{},"ISSN":["0003-4266"],"issn-type":[{"type":"print","value":"0003-4266"}],"subject":[],"published":{"date-parts":[[2007,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Insuffisance aortique sous\u00a0faibles doses de\u00a0cabergoline pour\u00a0hyperprolactin\u00e9mie non tumorale","name":"articletitle","label":"Article Title"},{"value":"Annales d'Endocrinologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ando.2007.08.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}